Sources | Names Used |
---|---|
CTRPv2 | Compound 1541A |
PharmacoGx | Compound 1541A |
Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | TP53TG3B | CTRPv2 | pan-cancer | AAC | -0.079 | 0.05 |
mRNA | ZNF548 | CTRPv2 | pan-cancer | AAC | 0.083 | 0.05 |
mRNA | CYP4V2 | CTRPv2 | pan-cancer | AAC | 0.081 | 0.05 |
mRNA | RAB5B | CTRPv2 | pan-cancer | AAC | 0.077 | 0.05 |
mRNA | MT-ND4L | CTRPv2 | pan-cancer | AAC | -0.088 | 0.05 |
mRNA | ZNF525 | CTRPv2 | pan-cancer | AAC | 0.078 | 0.05 |
mRNA | LARP7 | CTRPv2 | pan-cancer | AAC | 0.08 | 0.05 |
mRNA | NPHP4 | CTRPv2 | pan-cancer | AAC | 0.077 | 0.05 |
mRNA | TMEM242 | CTRPv2 | pan-cancer | AAC | 0.077 | 0.05 |
mRNA | SPDL1 | CTRPv2 | pan-cancer | AAC | -0.082 | 0.05 |